Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Related Posts
AI chatbots aren’t reliable for voting information, government officials warn
U.S. government officials are cautioning voters against relying on artificial intelligence chatbots for election-related questions.
House Speaker Johnson downplays deficit concerns as budget bill faces skeptics in Senate
Speaker Mike Johnson rejected concerns that the “big, beautiful bill” will add to the federal deficit.
Trump’s eye on Qatar’s $400M luxury jet is already causing a stir
Democratic lawmakers and Trump allies have criticized the purported move, saying the lavish nature of the gift raises serious legal and ethical concerns.